Senior insider sale
Chief Executive Officer at GALECTIN THERAPEUTICS INC — senior position signals high conviction
$1.40M
228.71K shares
What this filing means
SHLEVIN HAROLD H. plans to sell 228.71K shares of GALECTIN THERAPEUTICS INC valued at approximately $1.40M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/17/2025ACC: 0001628280-25-057679
Officer· Chief Executive Officer
Since Jan 2019
228.71K
Shares to sell
$1.40M
Approx. market value
24.71K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months2
STOCK OPTION
CASH
12/17/2025
20KSTOCK OPTION
CASH
6/4/2019
4.71KTotal acquired24.71K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/17/2025 | STOCK OPTION CASH | 20K | — |
6/4/2019 | STOCK OPTION CASH | 4.71K | — |
| Total | 24.71K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
8.42K
Market value
$52.5K
12/15/2025
—Completed
Units to sell
19.79K
Market value
$123.0K
12/12/2025
—Completed
Units to sell
16.79K
Market value
$104.2K
12/9/2025
—Completed
Units to sell
159K
Market value
$943.4K
12/8/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
24.71K
Market value
$172.2K
12/17/2025
Total
Units
228.71K
Value
$1.40M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/15/2025 | 8.42K | $52.5K | — | Completed |
12/12/2025 | 19.79K | $123.0K | — | Completed |
12/9/2025 | 16.79K | $104.2K | — | Completed |
12/8/2025 | 159K | $943.4K | — | Completed |
| Planned — Approximate Date | ||||
12/17/2025 | 24.71K | $172.2K | NASDAQ | Planned |
| Total | 228.71K | $1.40M | ||